Case Review: Xylazine Withdrawal Management

The presence of xylazine in the drug supply has further complicated withdrawal management for patients. In this case, we will explore a case article co-authored by Dr. Ehrman-Dupre and Dr. Kaigh describing withdrawal management for a patient being treated for wounds who had both xylazine and fentanyl dependence.


Cost: None

CME Accredited 

May 26, 2022
8:00 am — 9:00 am
Training Type Wound and Skin and Soft Tissue Morbidity and Mortality Review Workgroup